Eggert, Angelika 1967-
Angelika Eggert wetenschapper
VIAF ID: 237896295 (Personal)
Permalink: http://viaf.org/viaf/237896295
Preferred Forms
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Euro |
|
| Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature |
|
| Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology |
|
| Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience |
|
| Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. |
|
| Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis |
|
| Combined inhibition of Aurora-A and ATR kinase results in regression of <i>MYCN</i>-amplified neuroblastoma |
|
| Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy |
|
| German Cancer Consortium (DKTK) - a national consortium for translational cancer research |
|
| The landscape of genomic alterations across childhood cancers |
|
| A mechanistic classification of clinical phenotypes in neuroblastoma |
|
| Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification |
|
| The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma. |
|
| MiR-34a deficiency accelerates medulloblastoma formation in vivo |
|
| miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin |
|
| miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples |
|
| MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma |
|
| Neuroblastoma signalling models unveil combination therapies targeting feedback-mediated resistance |
|
| Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction |
|
| Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot study |
|
| Overall genomic pattern is a predictor of outcome in neuroblastoma |
|
| Pädiatrische Hämatologie und Onkologie |
|
| Passenger Gene Coamplifications Create Collateral Therapeutic Vulnerabilities in Cancer |
|
| Präparation und Charakterisierung Adenovirus Typ 12-spezifischer polyklonaler Antikörper, gerichtet gegen spezifische E1A-Tumorantigene |
|
| Pre-operative radiotherapy is associated with superior local relapse-free survival in advanced synovial sarcoma |
|
| A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization |
|
| Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions |
|
| World Congress Integrative Medicine & Health 2017: part two: Berlin, Germany. 3–5 May 2017. |
|
